Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1259 |
---|---|
Product Name | Anti-Human ALB & TNFA Recombinant Antibody |
Molecular Name | Ozoralizumab |
Alias | Anti-ALB & TNFA Recombinant Antibody, Research Grade Ozoralizumab |
CAS Number | 1167985-17-2 |
Target | ALB & TNFA[Homo sapiens] |
Isotype | VH-VH'-VH |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Buffer | PBS, pH7.5 |
Background | Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases. Ozoralizumab was developed by Pfizer Inc, and now belongs to Ablynx NV. Ablynx has licensed the rights to the antibody in China to Eddingpharm. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |